Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer-Reference-Cited by-同舟云学术

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer

Published:2020-04-17 Issue:4 Volume:15 Page:e0231786
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tutzauer Julia,Sjöström Martin^ORCID,Bendahl Pär-Ola,Rydén Lisa,Fernö Mårten,Leeb-Lundberg L. M. Fredrik^ORCID,Alkner Sara

Funder

Cancerfonden

Vetenskapsrådet

Swedish Breast Cancer Association

Skåne University Hospital foundation

Percy Falks Stiftelse för Forskning Beträffande Prostata- och Bröstcancer

Skåne County Council's Research and Development Foundation

Swedish Governmental Funding of Clinical Research within the National Health Service

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study;HO Adami;Cancer,1985

2. Epidemiology of contralateral breast cancer;Y Chen;Cancer Epidemiol Biomarkers Prev,1999

3. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2;KE Malone;J Clin Oncol,2010

4. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases;CL Carter;Cancer,1989

5. Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM);MJ Duffy;Eur J Cancer,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, characterization, preliminary molecular docking, pharmacological activity, and ADME studies of some new pyrazoline derivatives as anti-breast cancer agents;Pharmacia;2024-09-11

2. The GPR30 Receptor Is Involved in IL-6-Induced Metastatic Properties of MCF-7 Luminal Breast Cancer Cells;International Journal of Molecular Sciences;2024-08-18

3. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

4. G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells;Archives of Biochemistry and Biophysics;2024-02

5. Oestrogen receptor-independent actions of oestrogen in cancer;Molecular Biology Reports;2023-09-20